LifeMD
Overview
Publicly traded direct-to-patient telehealth company offering virtual primary care and weight management, with manufacturer partnerships giving patients access to Novo Nordisk's Wegovy via NovoCare Pharmacy at $499/month and to Eli Lilly's Zepbound through LillyDirect integration.
Notable
Publicly traded (NASDAQ: LFMD); stock rose sharply on its 2025 Novo Nordisk Wegovy distribution deal.
Key services
- virtual primary care
- GLP-1 weight management programs
- manufacturer pharmacy channel integration
- chronic condition management
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of LifeMD? Share your experience in a short, confidential interview.
Share your experience